India's pharma biz can reach USD 130 billion by 2030: Industry expertsChairman of PharmExcil (Pharmaceuticals Export Promotion Council of India) Veeramani S V said the Indian pharmaceutical industry is on a co...
CCI approves Multiples PE Fund and CPPIB investments in Acko TechnologyThe Competition Commission of India (CCI) has approved the acquisition of additional Series E compulsorily convertible preference shares of...
CCI clears Abu Dhabi Investment Authority's minority stake buy in Intas PharmaceuticalsPlatinum Owl is acting in its capacity as a trustee for Platinum Jasmine A 2018 Trust and Abu Dhabi Investment Authority (ADIA) is the sole...
Noida-based India Exposition Mart gets Sebi nod for IPOThe initial share sale comprises a fresh issue of equity shares aggregating up to Rs 450 crore, with a face value of Rs 5 each and an offer...
Government needs proactive approach to boost pharma sector: IndustryThe Indian pharmaceutical industry, with current market size of USD 27.57 billion is expected to reach USD 55 billion by 2020 growing at a ...
ET’s weekly roundup of the wackiest whispers and murmursET’s weekly roundup of the wackiest whispers and murmurs in corporate corridors and policy parlours.
CEOs of pharma cos to discuss key challenges within industryThe 10th edition of CPhI India, which is touted as South Asia's largest pharma event will take place between November 21 and 23.
CEOs of pharma companies to discuss key challenges within industryThe 10th edition of CPhI India, which is touted as South Asia's largest pharma event will take place between November 21 and 23.
Bulk drugs from China floods Indian market, leaves indigenous products in dire straitsThe Indian bulk drug industry is in dire straits and their prospects appear bleak unless the government takes immediate steps to support th...
230 Indian pharma firms in CPhI Worldwide fair in ParisParticipation of Indian firms is expected to increase awareness about the domestic pharmaceutical industry amongst the global stakeholders.
Government, pharma industry form 'India-Responsible Healthcare Trust'The government and major pharmaceutical industry organisations have come together to form the 'India-Responsible Healthcare Trust'.
India eyes $40 billion global generic market; patents held by MNCs to expire in over 3 yearsAnalysts say the timing to promote Indian generics globally is just right as the next three years will be crucial in terms of opportunity.
- Don't look now, Cipla just might be changing, says Cipla chairman & MD Dr Yusuf Hamied
ET delves into why one of India's oldest and best-known pharma companies is taking a hard look at itself.
Bloodbath for hospitalityIn a show of solidarity, hotel companies like Hyatt, Mariott, ITC, Four Seasons and The Leela have approached the Oberoi-Trident and Taj to...